FACTORS ASSOCIATED WITH BLEEDING EVENTS IN PATIENTS ON RIVAROXABAN FOR NON-VALVULAR ATRIAL FIBRILLATION: A REAL WORLD EXPERIENCE

被引：1
|
作者：
Akhtar, Tauseef [1 ]
Mattumpuram, Jishanth [1 ]
Fugar, Setri [1 ]
Ranka, Sagar [1 ]
Fratti, Juan Del Cid [1 ]
Mann, Hashim [1 ]
Uprety, Alok [1 ]
Putta, Aakash [1 ]
Golzar, Yasmeen [1 ]
机构：
[1] John H Stroger Hosp Cook Cty, Chicago, IL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)31079-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1267-270
引用
收藏
页码：471 / 471
页数：1
相关论文
共 50 条
  • [1] Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience
    Akhtar, Tauseef
    Fratti, Juan Del Cid
    Mattumpuram, Jishanth
    Fugar, Setri
    Uprety, Alok
    Nwaichi, Chineme
    Torres, Andrea
    Mann, Hashim
    Golzar, Yasmeen
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 320 : 78 - 82
  • [2] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban
    Abdullah, Ahmad Salihin
    Tan, Hwee Pheng
    Mohd Saffian, Shamin
    [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
  • [3] Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban
    Tepper, Ping G.
    Mardekian, Jack
    Masseria, Cristina
    Phatak, Hemant
    Kamble, Shital
    Abdulsattar, Younos
    Petkun, William
    Lip, Gregory Y. H.
    [J]. PLOS ONE, 2018, 13 (11):
  • [4] BLEEDING RISK AMONG JAPANESE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATED ON APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN IN THE REAL WORLD
    Wang, Feng
    Murata, Tatsunori
    Izumi, Naoko
    Kida, Makoto
    Horblyuk, Ruslan
    Terayama, Yasuo
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 443 - 443
  • [5] Real world comparison of major bleeding risk among non-valvular atrial fibrillation patients newly initiated on apixaban, dabigatran, rivaroxaban or warfarin
    Lip, G. Y. H.
    Pan, X.
    Kamble, S.
    Kawabata, H.
    Mardekian, J.
    Masseria, C.
    Bruno, A.
    Phatak, H.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 : 1085 - 1085
  • [6] RIVAROXABAN IN PREVENTION OF STROKE IN ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Yavelov, I. S.
    [J]. KARDIOLOGIYA, 2019, 59 (12) : 4 - 11
  • [7] Factors Associated with Outcome in Stroke Patients with Non-Valvular Atrial Fibrillation
    Maruyama, Kenji
    Shiga, Tsuyoshi
    Iijima, Mutsumi
    Uchiyama, Shinichiro
    Kitagawa, Kazuo
    [J]. CEREBROVASCULAR DISEASES, 2014, 38 : 65 - 66
  • [8] Real - world evidence of stroke prevention in patients with non-valvular atrial fibrillation
    Coleman, C.
    Antz, M.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 502 - 502
  • [9] Major Bleeding in Rivaroxaban Users with Non-Valvular Atrial Fibrillation in an Older Adult Population
    Tamayo, S.
    Patel, M.
    Yuan, Z.
    Sicignano, N.
    Hopf, K.
    Peacock, F.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S221 - S221
  • [10] Fatal acute haemopericardium associated with rivaroxaban in a patient with non-valvular atrial fibrillation
    Omer, Siddiq
    Magezi, Frederick
    Patel, Martyn
    Alsawaf, Ali
    [J]. AGE AND AGEING, 2019, 48 (05) : 758 - 760
12345